We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+8.23%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$6.27B
AUM Growth
-$229M
Cap. Flow
-$45.7M
Cap. Flow %
-0.73%
Top 10 Hldgs %
12.83%
Holding
1,678
New
564
Increased
243
Reduced
243
Closed
452

Top Buys

Rank Stock Value
1
ACI icon
Albertsons Companies
ACI
+$18.3M
2
CVX icon
Chevron
CVX
+$18M
3
AVGO icon
Broadcom
AVGO
+$17.8M
4
FYBR
Frontier Communications
FYBR
+$13.7M
5
CRH icon
CRH
CRH
+$9.45M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.45%
2 Communication Services 2.63%
3 Financials 2.29%
4 Healthcare 2.13%
5 Technology 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
1251
Annexon
ANNX
$802M
-400,600
Closed -$1.96M
ANNX icon
1252
PUT
Annexon
ANNX
$802M
-447,900
Closed -$2.19M
ANSS
1253
DELISTED
Ansys
ANSS
-13,000
Closed -$4.13M
ANVS icon
1254
PUT
Annovis Bio
ANVS
$48.7M
-125,000
Closed -$720K
APD icon
1255
CALL
Air Products & Chemicals
APD
$63.3B
-58,800
Closed -$15.2M
APEI icon
1256
CALL
American Public Education
APEI
$803M
-40,000
Closed -$703K
APP icon
1257
Applovin
APP
$103B
-12,266
Closed -$1.12M
AQN icon
1258
Algonquin Power & Utilities
AQN
$4.12B
-9,000
Closed -$51.2K
ARCT icon
1259
CALL
Arcturus Therapeutics
ARCT
$456M
-60,000
Closed -$1.46M
ARCT icon
1260
PUT
Arcturus Therapeutics
ARCT
$456M
-60,000
Closed -$1.46M
ARGX icon
1261
argenx
ARGX
$62B
-9,599
Closed -$4.85M
ARQT icon
1262
PUT
Arcutis Biotherapeutics
ARQT
$3.19B
-150,000
Closed -$1.4M
ASND icon
1263
Ascendis Pharma A/S
ASND
$15.6B
-4,600
Closed -$621K
ATEC icon
1264
Alphatec Holdings
ATEC
$1.57B
-53,000
Closed -$554K
ATEC icon
1265
PUT
Alphatec Holdings
ATEC
$1.57B
-85,000
Closed -$888K
ATEX icon
1266
Anterix
ATEX
$1.51B
-4,500
Closed -$178K
ATEX icon
1267
PUT
Anterix
ATEX
$1.51B
-25,000
Closed -$990K
ATRC icon
1268
AtriCure
ATRC
$2.96B
-270
Closed -$6.15K
AUPH icon
1269
Aurinia Pharmaceuticals
AUPH
$2.25B
-6,076
Closed -$37.7K
AVAV icon
1270
AeroVironment
AVAV
$8.13B
-1,850
Closed -$337K
AVAV icon
1271
PUT
AeroVironment
AVAV
$8.13B
-15,000
Closed -$2.73M
JBIO
1272
CALL
Jade Biosciences
JBIO
$1.08B
-269
Closed -$15.6K
JBIO
1273
Jade Biosciences
JBIO
$1.08B
-200
Closed -$11.6K
AXS icon
1274
AXIS Capital
AXS
$7.24B
-3,200
Closed -$240K
AZN icon
1275
AstraZeneca
AZN
$258B
-3,150
Closed -$508K

Similar funds

Caption Management's Q3 2024 Portfolio in Review

As of Q3 2024, Caption Management held 1,678 positions worth $6.27B, down 3.5% from $6.49B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Caption Management's Q3 2024 filing shows 564 new, 243 increased, 243 reduced and 452 closed positions. Its largest new stake was Albertsons Companies: 935,000 shares worth $17.3M. The largest sale was Verizon, an estimated $44M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 87% a quarter earlier, followed by Communication Services and Financials.

  • Caption Management's largest Q3 2024 buy was Albertsons Companies: 935,000 shares worth $17.3M.
  • Caption Management added most to Chevron in Q3 2024, an estimated $18M increase.
  • Caption Management's biggest Q3 2024 reduction was Verizon, cutting an estimated $44M.
  • Caption Management fully exited First Solar in Q3 2024, selling an estimated $23.2M.
  • Caption Management's ten largest holdings make up 13% of its $6.27B portfolio in Q3 2024.
  • Caption Management opened 564 new positions and closed 452 in Q3 2024.
  • Caption Management's portfolio value fell 3.5% quarter-over-quarter to $6.27B.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.